Phenotypic and functional analysis of human CD3+ and CD3- clones with 'lymphokine-activated killer' (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce Interleukin-2

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Clones capable of lysing fresh, uncultured tumor cells ('lymphokine-activated killer': 'LAK' activity) were selected from microcultures derived from either E-rosette-positive or E-rosette-negative cell populations. All the selected clones displayed a strong cytolytic activity against the NK-sensitive K562 cell line. Two major phenotypic groups of clones could be identified: a first group expressed the CD3 differentiation antigen, present exclusively on mature T lymphocytes; however, in contrast to typical cytolytic T lymphocytes, the majority of these clones expressed the unusual CD4- CD8- phenotype, whereas the remainder were CD4- CD8+. A second group was represented by CD3- clones which, in most instances, expressed the T-cell-lineage-specific CD2 antigen. Following stimulation with phytohemagglutinin (PHA), most of the CD3+ LAK clones produced Interleukin-2 (IL-2) and interferon-γ (IFN-γ) whereas those expressing the CD3- phenotype did not. Since previous studies indicated that PHA may be inefficient in inducing lymphokine production by T-cell variants lacking the CD3/T cell receptor complex (TCR), CD3- clones were further stimulated with the calcium ionophore A23187 plus phorbol 12-myristate 13-acetate (PMA). Only 2/11 CD3- LAK clones produced small amounts of IL-2, whereas the majority released IFN-γ. Given the peculiar phenotypic and functional properties of many CD3+ LAK clones, we suggest that they may belong to a T-cell subset distinct from typical CTLs.

Original languageEnglish
Pages (from-to)495-498
Number of pages4
JournalInternational Journal of Cancer
Volume40
Issue number4
Publication statusPublished - 1987

Fingerprint

Lymphokines
Interleukin-2
Clone Cells
CD3 Antigens
T-Lymphocytes
Phytohemagglutinins
Interferons
CD2 Antigens
Phenotype
Lymphokine-Activated Killer Cells
K562 Cells
Calcium Ionophores
Differentiation Antigens
Calcimycin
T-Lymphocyte Subsets
Cell Lineage
T-Cell Antigen Receptor
Acetates
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

@article{c30309a0de5b4cfe825f58525857bdb6,
title = "Phenotypic and functional analysis of human CD3+ and CD3- clones with 'lymphokine-activated killer' (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce Interleukin-2",
abstract = "Clones capable of lysing fresh, uncultured tumor cells ('lymphokine-activated killer': 'LAK' activity) were selected from microcultures derived from either E-rosette-positive or E-rosette-negative cell populations. All the selected clones displayed a strong cytolytic activity against the NK-sensitive K562 cell line. Two major phenotypic groups of clones could be identified: a first group expressed the CD3 differentiation antigen, present exclusively on mature T lymphocytes; however, in contrast to typical cytolytic T lymphocytes, the majority of these clones expressed the unusual CD4- CD8- phenotype, whereas the remainder were CD4- CD8+. A second group was represented by CD3- clones which, in most instances, expressed the T-cell-lineage-specific CD2 antigen. Following stimulation with phytohemagglutinin (PHA), most of the CD3+ LAK clones produced Interleukin-2 (IL-2) and interferon-γ (IFN-γ) whereas those expressing the CD3- phenotype did not. Since previous studies indicated that PHA may be inefficient in inducing lymphokine production by T-cell variants lacking the CD3/T cell receptor complex (TCR), CD3- clones were further stimulated with the calcium ionophore A23187 plus phorbol 12-myristate 13-acetate (PMA). Only 2/11 CD3- LAK clones produced small amounts of IL-2, whereas the majority released IFN-γ. Given the peculiar phenotypic and functional properties of many CD3+ LAK clones, we suggest that they may belong to a T-cell subset distinct from typical CTLs.",
author = "Mingari, {M. C.} and S. Ferrini and D. Pende and C. Bottino and I. Prigione and A. Moretta and L. Moretta",
year = "1987",
language = "English",
volume = "40",
pages = "495--498",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Phenotypic and functional analysis of human CD3+ and CD3- clones with 'lymphokine-activated killer' (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce Interleukin-2

AU - Mingari, M. C.

AU - Ferrini, S.

AU - Pende, D.

AU - Bottino, C.

AU - Prigione, I.

AU - Moretta, A.

AU - Moretta, L.

PY - 1987

Y1 - 1987

N2 - Clones capable of lysing fresh, uncultured tumor cells ('lymphokine-activated killer': 'LAK' activity) were selected from microcultures derived from either E-rosette-positive or E-rosette-negative cell populations. All the selected clones displayed a strong cytolytic activity against the NK-sensitive K562 cell line. Two major phenotypic groups of clones could be identified: a first group expressed the CD3 differentiation antigen, present exclusively on mature T lymphocytes; however, in contrast to typical cytolytic T lymphocytes, the majority of these clones expressed the unusual CD4- CD8- phenotype, whereas the remainder were CD4- CD8+. A second group was represented by CD3- clones which, in most instances, expressed the T-cell-lineage-specific CD2 antigen. Following stimulation with phytohemagglutinin (PHA), most of the CD3+ LAK clones produced Interleukin-2 (IL-2) and interferon-γ (IFN-γ) whereas those expressing the CD3- phenotype did not. Since previous studies indicated that PHA may be inefficient in inducing lymphokine production by T-cell variants lacking the CD3/T cell receptor complex (TCR), CD3- clones were further stimulated with the calcium ionophore A23187 plus phorbol 12-myristate 13-acetate (PMA). Only 2/11 CD3- LAK clones produced small amounts of IL-2, whereas the majority released IFN-γ. Given the peculiar phenotypic and functional properties of many CD3+ LAK clones, we suggest that they may belong to a T-cell subset distinct from typical CTLs.

AB - Clones capable of lysing fresh, uncultured tumor cells ('lymphokine-activated killer': 'LAK' activity) were selected from microcultures derived from either E-rosette-positive or E-rosette-negative cell populations. All the selected clones displayed a strong cytolytic activity against the NK-sensitive K562 cell line. Two major phenotypic groups of clones could be identified: a first group expressed the CD3 differentiation antigen, present exclusively on mature T lymphocytes; however, in contrast to typical cytolytic T lymphocytes, the majority of these clones expressed the unusual CD4- CD8- phenotype, whereas the remainder were CD4- CD8+. A second group was represented by CD3- clones which, in most instances, expressed the T-cell-lineage-specific CD2 antigen. Following stimulation with phytohemagglutinin (PHA), most of the CD3+ LAK clones produced Interleukin-2 (IL-2) and interferon-γ (IFN-γ) whereas those expressing the CD3- phenotype did not. Since previous studies indicated that PHA may be inefficient in inducing lymphokine production by T-cell variants lacking the CD3/T cell receptor complex (TCR), CD3- clones were further stimulated with the calcium ionophore A23187 plus phorbol 12-myristate 13-acetate (PMA). Only 2/11 CD3- LAK clones produced small amounts of IL-2, whereas the majority released IFN-γ. Given the peculiar phenotypic and functional properties of many CD3+ LAK clones, we suggest that they may belong to a T-cell subset distinct from typical CTLs.

UR - http://www.scopus.com/inward/record.url?scp=0023619503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023619503&partnerID=8YFLogxK

M3 - Article

C2 - 3117711

AN - SCOPUS:0023619503

VL - 40

SP - 495

EP - 498

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -